PEG & ADCs
- How to Choose the Right ADC Linker: Cleavability, Conjugation Chemistry, and PEG Design
- What Are ADC Linkers: Cleavable vs. Non-Cleavable Linkers
- Next-Generation ADC: Bispecific & Multi-Payload Trends
- Review: Hydrophilic linkers in Antibody-drug Conjugates
- Topoisomerase I inhibitors Based ADCs: SN-38 & DXd
- The Bystander Effect of ADCs
- FDA Approved Antibody-Drug Conjugates (ADCs) By 2026
- First Bispecific ADC Approved Globally: More Bispecific ADCs in Clinical Trials
- 23 Antibody-drug Conjugates (ADCs) Approved Globally
- ADC Advances in 2026: New Approvals and Emerging Breakthroughs
